In Q1 2026, Westlake Corporation reported softer sales driven by price reductions and a net operating loss primarily in the Performance and Essential Materials (PEM) segment. The company continues to reshape its asset base with recent North American chlorovinyl facility closures and the acquisition of ACI to expand specialty compounds. These near-term pressures underscore the cyclical challenges in commodity chemicals, while Westlake’s vertical integration offers operational resilience. Maintaining ample liquidity and a stable capital structure supports ongoing strategic initiatives despite earnings pressure.